L'impact des infections bactériennes sur le risque de cancer

Par Priscille Tremblais Publié le 04/02/2020 Mis à jour le 04/02/2020 Edition Abonné
Article

Les infections participent à la survenue d'environ 20% des cancers. Si les virus sont en première ligne, certaines bactéries ne sont cependant pas loin. Voici le rôle des infections bactériennes dans la genèse des cancers les plus mortels, et ce que cela peut signifier en termes de traitement.

Le cancer est causé principalement par des altérations des gènes. Et si ces altérations sont imputables à divers facteurs, elles peuvent être, entre autres, induites par des infections. Ce serait le cas pour environ 20% des cancers. Le plus souvent ces infections participant à l'initiation d’un cancer sont virales, à...

Références
  1. de Oliveira DE, Müller-Coan BG, Pagano JS. Viral carcinogenesis beyond malignant transformation: EBV in the progression of human cancers. Trends in microbiology. 2016;24(8):649-64.
  2. Botelho MC, Alves H, Richter J. Halting Schistosoma haematobium-associated bladder cancer. International journal of cancer management. 2017;10(9).
  3. Scanu T, Spaapen RM, Bakker JM, Pratap CB, Wu LE, Hofland I, et al. Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma. Cell Host Microbe. 2015;17(6):763-74.

  4. Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. International journal of cancer. 2015;136(2):487-90.

  5. Blaser MJ, Webb GF. Host demise as a beneficial function of indigenous microbiota in human hosts. MBio. 2014;5(6):e02262-14.

  6. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, et al. Molecular analysis of the bacterial microbiota in the human stomach. Proceedings of the National Academy of Sciences. 2006;103(3):732-7.

  7. Eyvazi S, Hakemi-Vala M. A Review Article on Helicobacter pylori Antibiotic Resistance Profile in Iran. Int J Trop Dis Health. 2015;10(1):1-12.

  8. Cancer IAfRo. Schistosomes, liver flukes and Helicobacter pylori: IARC Lyon; 1994.

  9. Larussa T, Leone I, Suraci E, Imeneo M, Luzza F. Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance. J Immunol Res. 2015;2015:981328.

  10. Mashayekhi F, Moghny M, Faramarzpoor M, Yahaghi E, Khodaverdi Darian E, Tarhriz V, et al. Molecular characterization and antimicrobial resistance of uropathogenic Escherichia coli. Iranian Journal of Biotechnology. 2014;12(2):32-40.

  11. Burns CA, McCaughey R, Lauter CB. The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential. American Journal of Gastroenterology. 1985;80(1).

  12. Aymeric L, Donnadieu F, Mulet C, du Merle L, Nigro G, Saffarian A, et al. Colorectal cancer specific conditions promote Streptococcus gallolyticus gut colonization. Proceedings of the National Academy of Sciences. 2018;115(2):E283-E91.

  13. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. 2015;136(5):E359-E86.

  14. Holmes RS, Vaughan TL, editors. Epidemiology and pathogenesis of esophageal cancer. Seminars in radiation oncology; 2007: Elsevier.

  15. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO reports. 2006;7(7):688-93.

  16. Gagliardi D, Makihara S, Corsi P, De Toledo Viana A, Wiczer M, Nakakubo S, et al. Microbial flora of the normal esophagus. Diseases of the Esophagus. 1998;11(4):248-50.

  17. Blackett K, Siddhi S, Cleary S, Steed H, Miller M, Macfarlane S, et al. Oesophageal bacterial biofilm changes in gastro‐oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality? Alimentary pharmacology & therapeutics. 2013;37(11):1084-92.

  18. Sawada A, Fujiwara Y, Nagami Y, Tanaka F, Yamagami H, Tanigawa T, et al. Alteration of esophageal microbiome by antibiotic treatment does not affect incidence of rat esophageal adenocarcinoma. Digestive diseases and sciences. 2016;61(11):3161-8.

  19. Zaidi AH, Kelly LA, Kreft RE, Barlek M, Omstead AN, Matsui D, et al. Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma. BMC Cancer. 2016;16:52.

  20. Yamamura K, Baba Y, Nakagawa S, Mima K, Miyake K, Nakamura K, et al. Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis. Clin Cancer Res. 2016;22(22):5574-81.

  21. Apostolou P, Tsantsaridou A, Papasotiriou I, Toloudi M, Chatziioannou M, Giamouzis G. Bacterial and fungal microflora in surgically removed lung cancer samples. Journal of cardiothoracic surgery. 2011;6(1):137.

  22. Huang Q, Duan L, Qian X, Fan J, Lv Z, Zhang X, et al. IL-17 Promotes Angiogenic Factors IL-6, IL-8, and Vegf Production via Stat1 in Lung Adenocarcinoma. Sci Rep. 2016;6:36551.

  23. Hillemanns P, Soergel P, Hertel H, Jentschke M. Epidemiology and Early Detection of Cervical Cancer. Oncol Res Treat. 2016;39(9):501-6.

  24. Di Paola M, Sani C, Clemente AM, Iossa A, Perissi E, Castronovo G, et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection. Sci Rep. 2017;7(1):10200

  25. Pavic N. Is there a local production of nitrosamines by the vaginal microflora in anaerobic vaginosis/trichomoniasis? Med Hypotheses. 1984;15(4):433-6.

  26. Biswal BM, Singh KKB, Ismail MB, Jalal MIBA, Safruddin EISBE. Current Concept of Bacterial Vaginosis in Cervical Cancer. Journal of Clinical Gynecology and Obstetrics. 2014;3(1):1-7.

  27. Mikamo H, Izumi K, Ito K, Watanabe K, Ueno K, Tamaya T. Internal bacterial flora of solid uterine cervical cancer. Kansenshogaku Zasshi. 1993;67(11):1057-61.

  28. Audirac-Chalifour A, Torres-Poveda K, Bahena-Roman M, Tellez-Sosa J, Martinez-Barnetche J, Cortina-Ceballos B, et al. Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study. PLoS One. 2016;11(4):e0153274.

  29. Mikamo H, Sato Y, Hayasaki Y, Kawazoe K, Izumi K, Ito K, et al. Intravaginal bacterial flora in patients with uterine cervical cancer. High incidence of detection of Gardnerella vaginalis. J Infect Chemother. 1999;5(2):82-5.

  30. Xie X, Yang M, Ding Y, Chen J. Microbial infection, inflammation and epithelial ovarian cancer. Oncology letters. 2017;14(2):1911-9.

  31. Edgar RC. UNOISE2: improved error-correction for Illumina 16S and ITS amplicon sequencing. BioRxiv. 2016:081257.

  32. Amir A, McDonald D, Navas-Molina JA, Kopylova E, Morton JT, Xu ZZ, et al. Deblur rapidly resolves single-nucleotide community sequence patterns. MSystems. 2017;2(2):e00191-16.

  33. Yu Y, Champer J, Beynet D, Kim J, Friedman AJ. The role of the cutaneous microbiome in skin cancer: lessons learned from the gut. Journal of drugs in dermatology: JDD. 2015;14(5):461-5.

Cet article est réservé aux abonnés

Déjà abonné ?

Retrouvez la suite de votre article en vous connectant à votre espace personnel.

Je m'identifie
Pas encore abonné ?

Accédez à des articles et conseils exclusifs en vous abonnant pour seulement 39 € / an.

Je m'abonne
Publicité

La sélection

Publicité

Les meilleurs livres et compléments alimentaires sélectionnés pour vous par NUTRIVI, la boutique de la nutrition.

Découvrir la boutique logo Nutrivi

A découvrir également

Back to top